Ramipril and Acarodermatitis - a phase IV clinical study of FDA data

Summary:

Acarodermatitis is reported as a side effect among people who take Ramipril (ramipril), especially for people who are male, 60+ old, also take Mepivacaine Hydrochloride, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Acarodermatitis when taking Ramipril. It is created by eHealthMe based on reports of 144,209 people who have side effects when taking Ramipril from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,377 Ramipril users. Check the latest studies of Ramipril.

What is Acarodermatitis?

Acarodermatitis (skin inflammation caused by mites (acarids)) is found to be associated with 274 drugs and 306 conditions by eHealthMe. Check the latest studies of Acarodermatitis.

On Aug, 27, 2025

144,209 people reported to have side effects when taking Ramipril.
Among them, 14 people (0.01%) have Acarodermatitis.

Among these 14 people:

What is the gender of people who have Acarodermatitis when taking Ramipril? *

female: 50 %
male: 50 %

What is the age of people who have Acarodermatitis when taking Ramipril? *

What are other drugs people take besides Ramipril? *

Zopiclone: 3 people, 21.43%
Piroxicam: 3 people, 21.43%
Hydrochlorothiazide: 3 people, 21.43%
Furosemide: 3 people, 21.43%
Foradil: 3 people, 21.43%
Zolpidem: 3 people, 21.43%
Lasix: 3 people, 21.43%
Fentanyl: 3 people, 21.43%
Entresto: 3 people, 21.43%
Mepivacaine Hydrochloride: 3 people, 21.43%

What are other side effects people have besides Acarodermatitis? *

Dizziness: 7 people, 50.00%
Hypotension (abnormally low blood pressure): 6 people, 42.86%
Urinary Tract Infection: 6 people, 42.86%
Fatigue (feeling of tiredness): 6 people, 42.86%
Itching: 6 people, 42.86%
Nausea (feeling of having an urge to vomit): 6 people, 42.86%
Weight Increased: 5 people, 35.71%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 35.71%
Headache (pain in head): 5 people, 35.71%
Joint Pain: 5 people, 35.71%

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 42.86%
Basal Cell Carcinoma (a skin cancer, it rarely metastasizes or kills): 4 people, 28.57%
Cardiac Failure: 4 people, 28.57%
Sleep Disorder: 3 people, 21.43%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 21.43%
Anaesthesia: 3 people, 21.43%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 21.43%
Congestive Cardiomyopathy (weakening of heart muscle): 3 people, 21.43%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 21.43%
Local Anaesthesia: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Acarodermatitis?

- Check whether Acarodermatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ramipril:

Ramipril (147,377 reports)

Acarodermatitis treatments and more:

Acarodermatitis (2,497 reports)

How severe was Acarodermatitis and when was it recovered:

Acarodermatitis in Ramipril

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Acarodermatitis:

Acarodermatitis (274 drugs)

Browse all the conditions that are associated with Acarodermatitis:

Acarodermatitis (306 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.